Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
Over the last couple of decades there has been a significant increase in the burden of prostatic diseases, notably prostate cancer, in Asian countries. Along with that growth, we have seen a strong increase in the amount of research in Asia focused on prostate cancer. In this virtual issue of Prostate Cancer and Prostatic Diseases entitled “Best of Asia”, the journal’s Editor-in-Chief, Dr. Stephen Freedland, along with members of the editorial board in China, Drs. Dingwei Ye and Yao Zhu, selected the top articles published by authors in Asia over the past year. We hope you enjoy this hand-selected list that highlights the strengths and diversity of prostate-related research in Asia.
In 2017 and 2018, several notable advances have been made in the care of men with advanced or metastatic prostate cancer, and Prostate Cancer and Prostatic Diseases provides important insights and perspectives around each of these major advances. In this online collection, the editors of PCAN have selected ten key papers from the past year which highlight and provide novel insights into these important clinical and translational advances.
The Editor of Prostate Cancer and Prostatic Diseases is proud to share a selection of key papers that have published in the journal to celebrate 20 years of publication! These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers.
This supplement presents the latest research featured at the symposium on GnRH Analogues and Prostate Cancer, sponsored by Takeda Chemical Industries Ltd, and held during the 5th International Symposium on GnRH Analogues and Cancer and Human Reproduction in February 1999 in Geneva, Switzerland.